Showing 1 - 16 results of 16 for search 'Jashin J. Wu', query time: 0.04s
Refine Results
-
1
-
2
-
3
-
4
-
5
-
6
Treatment patterns and healthcare costs among patients with psoriasis initiating apremilast or biologics: a retrospective claims database cohort analysis by Jashin J. Wu, Ching An Wang, Greeta Jobson, David Davidson, Samaneh Kalirai, Julia Zhu, Manasi Suryavanshi, Mayank Mittal, Vardhaman Patel, Lauren Seigel
Published 2023-12-01
Article -
7
-
8
-
9
Predicting discontinuation of biologic therapy caused by adverse events in psoriasis patients—A Danish nationwide cohort study by Mia‐Louise Nielsen, Troels C. Petersen, Julia‐Tatjana Maul, Jashin J. Wu, Trine Bertelsen, Lone Skov, Simon F. Thomsen, Jacob P. Thyssen, Alexander Egeberg
Published 2023-12-01
Article -
10
Mapping the road to biologics in psoriasis and psoriatic arthritis: A nationwide drug utilization study by David Thein, Nana A. L. Rosenø, Mia‐Louise Nielsen, Lars Erik Kristensen, Julia‐Tatjana Maul, Jashin J. Wu, Simon Francis Thomsen, Jacob P. Thyssen, Alexander Egeberg
Published 2023-12-01
Article -
11
Varied treatment patterns among patients with palmoplantar pustulosis: A claims-based cohort study using data from 2 large US databases by Jashin J. Wu, MD, Ran Gao, MS, Rhonda L. Bohn, ScD, Anouk Déruaz-Luyet, PhD, Stephani Gray, MPH, Frank Baehner, MD, Steven R. Feldman, PhD
Published 2024-06-01
Article -
12
Poor adherence to and persistence with biologics in generalized pustular psoriasis: A claim-based study using real-world data from two large US databasesCapsule Summary by Steven R. Feldman, MD, Rhonda L. Bohn, ScD, Ran Gao, MS, Stephani Gray, MPH, Sabrina E. Walton, MSPH, Anouk Déruaz-Luyet, PhD, MPH, Jashin J. Wu, MD
Published 2024-06-01
Article -
13
Varied treatment pathways with no defined treatment sequencing in patients with generalized pustular psoriasis: A claims-based study by Steven R. Feldman, MD, PhD, Ran Gao, MS, Rhonda L. Bohn, ScD, Stephani Gray, MPH, Sabrina E. Walton, MSPH, Anouk Déruaz-Luyet, PhD, MPH, Jashin J. Wu, MD
Published 2024-06-01
Article -
14
Real-world Drug Survival of Biosimilar SB5 vs GP2017 Following a Mandatory Non-medical Switch from Adalimumab Originator for Psoriasis: A Nationwide Cohort Study by Johan Sieborg, Julia-Tatjana Maul, Jashin J. Wu, Nikolai Nguyen Loft, Lone Skov, Lars Erik Bryld, Mads Kirchheiner Rasmussen, Tomas Norman Dam, Trine Bertelsen, Kawa Khaled Ajgeiy, Simon Francis Thomsen, Jacob P. Thyssen, Alexander Egeberg, David Thein
Published 2025-03-01
Article -
15
Correlation between Dermatology Life Quality Index and Psoriasis Area and Severity Index in Patients with Psoriasis: A Cross-sectional Global Healthcare Study on Psoriasis by Julia-Tatjana Maul, Lara W. Maul, Johannes A. Didaskalu, Fernando Valenzuela, Ricardo Romiti, Hannah Peterson, Edwin Korouri, Farah Novoa, Hazel H. Oon, Min Zheng, Jashin J. Wu, Jacob P. Thyssen, Alexander Egeberg, April W. Armstrong, Mia-Louise Nielsen
Published 2024-03-01
Article -
16
Sex Disparities of Health-related Quality of Life in Moderate to Severe Psoriasis: A Real-world Analysis from the Swiss Psoriasis Registry (SDNTT) by Ramtin Lichtenberger, Lara Valeska Maul, Ion Birkenmaier, Iker Oyanguren, Melike Ak, Kristine Heidemeyer, Christoph Schlapbach, Nikhil Yawalkar, Alexander Egeberg, Simon Francis Thomsen, Jacob P. Thyssen, Christina Sorbe, Wolf-Henning Boehncke, Curdin Conrad, Antonio Cozzio, Georgios Kokolakis, Raphael Micheroli, Jashin J. Wu, Thomas Kündig, Alexander Navarini, Julia-Tatjana Maul
Published 2025-02-01
Article